Gerresheimer AG (GXI.DE)
EUR 75.75
(-3.13%)
EUR 75.75
(-3.13%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 323.34 Million EUR | 6.23% |
| 2022 | 304.38 Million EUR | 29.28% |
| 2021 | 235.44 Million EUR | 26.2% |
| 2020 | 186.56 Million EUR | 2.84% |
| 2019 | 181.4 Million EUR | 8.78% |
| 2018 | 166.77 Million EUR | 14.0% |
| 2017 | 146.29 Million EUR | -3.99% |
| 2016 | 152.38 Million EUR | -15.44% |
| 2015 | 180.21 Million EUR | -3.05% |
| 2014 | 185.87 Million EUR | 2.99% |
| 2013 | 180.47 Million EUR | -4.49% |
| 2012 | 188.95 Million EUR | 18.17% |
| 2011 | 159.9 Million EUR | 15.56% |
| 2010 | 138.37 Million EUR | 13.01% |
| 2009 | 122.43 Million EUR | -20.53% |
| 2008 | 154.06 Million EUR | 11.21% |
| 2007 | 138.53 Million EUR | 47.33% |
| 2006 | 94.02 Million EUR | 2.17% |
| 2005 | 92.03 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 350.99 Million EUR | 8.55% |
| 2024 Q2 | 365.89 Million EUR | 4.24% |
| 2024 Q3 | 371.86 Million EUR | 1.63% |
| 2023 Q3 | 353.35 Million EUR | 3.74% |
| 2023 FY | 323.34 Million EUR | 6.23% |
| 2023 Q1 | 343.84 Million EUR | 12.96% |
| 2023 Q2 | 340.62 Million EUR | -0.94% |
| 2023 Q4 | 323.34 Million EUR | -8.49% |
| 2022 Q3 | 323.16 Million EUR | 5.75% |
| 2022 Q4 | 304.38 Million EUR | -5.81% |
| 2022 FY | 304.38 Million EUR | 29.28% |
| 2022 Q1 | 272.22 Million EUR | 15.62% |
| 2022 Q2 | 305.58 Million EUR | 12.25% |
| 2021 Q1 | 218.52 Million EUR | 17.13% |
| 2021 Q3 | 243.29 Million EUR | 2.64% |
| 2021 FY | 235.44 Million EUR | 26.2% |
| 2021 Q4 | 235.44 Million EUR | -3.23% |
| 2021 Q2 | 237.03 Million EUR | 8.47% |
| 2020 FY | 186.56 Million EUR | 2.84% |
| 2020 Q1 | 210.46 Million EUR | 16.02% |
| 2020 Q4 | 186.56 Million EUR | -10.28% |
| 2020 Q3 | 207.93 Million EUR | -2.33% |
| 2020 Q2 | 212.9 Million EUR | 1.16% |
| 2019 Q3 | 193.66 Million EUR | -2.01% |
| 2019 Q1 | 184.52 Million EUR | 10.64% |
| 2019 FY | 181.4 Million EUR | 8.78% |
| 2019 Q2 | 197.64 Million EUR | 7.11% |
| 2019 Q4 | 181.4 Million EUR | -6.33% |
| 2018 Q2 | 175.76 Million EUR | 6.33% |
| 2018 FY | 166.77 Million EUR | 14.0% |
| 2018 Q4 | 166.77 Million EUR | -2.39% |
| 2018 Q3 | 170.85 Million EUR | -2.8% |
| 2018 Q1 | 165.3 Million EUR | 13.0% |
| 2017 Q1 | 167.97 Million EUR | 10.24% |
| 2017 FY | 146.29 Million EUR | -3.99% |
| 2017 Q4 | 146.29 Million EUR | -7.61% |
| 2017 Q3 | 158.34 Million EUR | -6.85% |
| 2017 Q2 | 169.99 Million EUR | 1.2% |
| 2016 FY | 152.38 Million EUR | -15.44% |
| 2016 Q3 | 183.47 Million EUR | -1.69% |
| 2016 Q2 | 186.61 Million EUR | 0.72% |
| 2016 Q1 | 185.29 Million EUR | 2.82% |
| 2016 Q4 | 152.38 Million EUR | -16.95% |
| 2015 Q3 | 178.35 Million EUR | -14.22% |
| 2015 Q4 | 180.21 Million EUR | 1.04% |
| 2015 Q2 | 207.91 Million EUR | 1.17% |
| 2015 Q1 | 205.52 Million EUR | 10.57% |
| 2015 FY | 180.21 Million EUR | -3.05% |
| 2014 Q4 | 185.87 Million EUR | -2.18% |
| 2014 Q3 | 190.01 Million EUR | 3.53% |
| 2014 Q2 | 183.53 Million EUR | 1.63% |
| 2014 Q1 | 180.58 Million EUR | 0.06% |
| 2014 FY | 185.87 Million EUR | 2.99% |
| 2013 Q4 | 180.47 Million EUR | -1.22% |
| 2013 Q3 | 182.71 Million EUR | -0.5% |
| 2013 Q2 | 183.62 Million EUR | -0.33% |
| 2013 Q1 | 184.22 Million EUR | -2.5% |
| 2013 FY | 180.47 Million EUR | -4.49% |
| 2012 Q2 | 190.69 Million EUR | 5.59% |
| 2012 FY | 188.95 Million EUR | 18.17% |
| 2012 Q4 | 188.95 Million EUR | -2.08% |
| 2012 Q3 | 192.98 Million EUR | 1.2% |
| 2012 Q1 | 180.6 Million EUR | 12.95% |
| 2011 FY | 159.9 Million EUR | 15.56% |
| 2011 Q3 | 158 Million EUR | -0.93% |
| 2011 Q2 | 159.49 Million EUR | 4.29% |
| 2011 Q4 | 159.9 Million EUR | 1.2% |
| 2011 Q1 | 152.93 Million EUR | 10.53% |
| 2010 FY | 138.37 Million EUR | 13.01% |
| 2010 Q4 | 138.37 Million EUR | -6.83% |
| 2010 Q3 | 148.5 Million EUR | 1.03% |
| 2010 Q2 | 146.99 Million EUR | 4.39% |
| 2010 Q1 | 140.81 Million EUR | 15.01% |
| 2009 FY | 122.43 Million EUR | -20.53% |
| 2009 Q4 | 122.43 Million EUR | 0.0% |
| 2008 FY | 154.06 Million EUR | 11.21% |
| 2007 FY | 138.53 Million EUR | 47.33% |
| 2006 FY | 94.02 Million EUR | 2.17% |
| 2005 FY | 92.03 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 138.94 Million EUR | -132.716% |
| Carl Zeiss Meditec AG | 520.22 Million EUR | 37.846% |
| Fielmann Aktiengesellschaft | 224.74 Million EUR | -43.874% |
| Sartorius Aktiengesellschaft | 1.03 Billion EUR | 68.813% |
| Sartorius Aktiengesellschaft | 1.03 Billion EUR | 68.813% |